We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-6.61%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$670M
AUM Growth
+$109M
Cap. Flow
+$144M
Cap. Flow %
21.49%
Top 10 Hldgs %
59.4%
Holding
184
New
14
Increased
76
Reduced
55
Closed
39

Sector Composition

Rank Sector Weight
1 Energy 73.91%
2 Healthcare 7.71%
3 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCP
26
DELISTED
TC Pipelines LP
TCP
$5.53M 0.83%
100,616
+32,850
+48% +$1.88M
ENLC
27
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$5.22M 0.78%
296,667
+97,018
+49% +$1.73M
WES icon
28
Western Midstream Partners
WES
$19.3B
$4.9M 0.73%
113,897
+37,306
+49% +$1.64M
MPC icon
29
Marathon Petroleum
MPC
$92.1B
$4.22M 0.63%
80,639
-118,574
-60% -$6.13M
TRGP icon
30
Targa Resources
TRGP
$60.6B
$3.41M 0.51%
75,368
+52,213
+225% +$2.63M
FTEC icon
31
Fidelity MSCI Information Technology Index ETF
FTEC
$19.8B
$3.05M 0.46%
71,455
+6,455
+10% +$276K
VPU
32
Vanguard Utilities ETF
VPU
$8.6B
$2.64M 0.39%
23,143
-2,057
-8% -$237K
FNCL icon
33
Fidelity MSCI Financials Index ETF
FNCL
$2.34B
$2.59M 0.39%
71,272
+17,372
+32% +$610K
CLVS
34
DELISTED
Clovis Oncology, Inc.
CLVS
$1.53M 0.23%
16,349
+8,552
+110% +$523K
WELL.PRI
35
DELISTED
Welltower Inc.
WELL.PRI
$1.36M 0.2%
20,494
+12,116
+145% +$790K
EXEL icon
36
Exelixis
EXEL
$14B
$1.3M 0.19%
52,621
-10,822
-17% -$229K
VNDA icon
37
Vanda Pharmaceuticals
VNDA
$320M
$1.22M 0.18%
74,733
+10,020
+15% +$144K
ACOR
38
DELISTED
Acorda Therapeutics
ACOR
$1.18M 0.18%
500
+83
+20% +$164K
ENTA icon
39
Enanta Pharmaceuticals
ENTA
$383M
$1.16M 0.17%
32,235
-286
-0.9% -$9.15K
CQP icon
40
Cheniere Energy
CQP
$30.9B
$1.15M 0.17%
35,434
+11,636
+49% +$371K
KERX
41
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$1.14M 0.17%
157,065
-26,842
-15% -$168K
ENB icon
42
Enbridge
ENB
$122B
$1.13M 0.17%
28,362
+9,252
+48% +$372K
GILD icon
43
Gilead Sciences
GILD
$165B
$1.13M 0.17%
15,926
+2,250
+16% +$150K
RDUS
44
DELISTED
Radius Health, Inc.
RDUS
$1.13M 0.17%
24,899
+18,119
+267% +$692K
VDE icon
45
Vanguard Energy ETF
VDE
$9.8B
$1.12M 0.17%
12,696
+5,126
+68% +$473K
CELG
46
DELISTED
Celgene Corp
CELG
$1.11M 0.17%
8,551
-389
-4% -$47.7K
BIIB icon
47
Biogen
BIIB
$29.5B
$1.11M 0.17%
4,085
+468
+13% +$124K
IRWD icon
48
Ironwood Pharmaceuticals
IRWD
$634M
$1.1M 0.16%
69,665
-9,330
-12% -$136K
TBPH icon
49
Theravance Biopharma
TBPH
$871M
$1.1M 0.16%
27,646
-5,808
-17% -$223K
TVTX icon
50
Travere Therapeutics
TVTX
$5.16B
$1.1M 0.16%
56,653
+5,036
+10% +$91.3K

Similar funds

Virtus ETF Advisers's Q2 2017 Portfolio in Review

As of Q2 2017, Virtus ETF Advisers held 184 positions worth $670M, up 19% from $562M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Virtus ETF Advisers deployed $144M of net new capital in Q2 2017, opening 14 new positions and adding to 76 existing holdings. Its largest new stake was Jounce Therapeutics, Inc. Common Stock: 18,442 shares worth $259K.

By sector, the portfolio is most concentrated in Energy at 74% of assets, up from 70% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Marathon Petroleum, an estimated $6.13M trimmed.

  • Virtus ETF Advisers's largest Q2 2017 buy was Jounce Therapeutics, Inc. Common Stock: 18,442 shares worth $259K.
  • Virtus ETF Advisers added most to Energy Transfer Partners, L.P. in Q2 2017, an estimated $71.8M increase.
  • Virtus ETF Advisers's biggest Q2 2017 reduction was Marathon Petroleum, cutting an estimated $6.13M.
  • Virtus ETF Advisers fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $45.5M.
  • Virtus ETF Advisers's ten largest holdings make up 59% of its $670M portfolio in Q2 2017.
  • Virtus ETF Advisers opened 14 new positions and closed 39 in Q2 2017.
  • Virtus ETF Advisers's portfolio value rose 19% quarter-over-quarter to $670M.

Based on Virtus ETF Advisers's 13F filing for Q2 2017, filed 14 Aug 2017.